R87.62AktuellKategorie · weitere Spezifizierung erforderlich

Abnormal cytological findings in specimens from vagina

Hinweise zum Code

Use additional code

code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)

Excludes 1

abnormal cytological findings in specimens from cervix uteri (R87.61-)
abnormal cytological findings in specimens from other female genital organs (R87.69)
carcinoma in situ of vagina (histologically confirmed) (D07.2)
vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
severe dysplasia of vagina (histologically confirmed) (D07.2)

R83-R89 · Hinweise übergeordneter Ebenen

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2 · 9

R87.62

Excludes 2

vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

Spezifischere Codes

R87.620Atypical squamous cells of undetermined significance on cytologic smear of vagina (ASC-US)R87.621Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)R87.622Low grade squamous intraepithelial lesion on cytologic smear of vagina (LGSIL)R87.623High grade squamous intraepithelial lesion on cytologic smear of vagina (HGSIL)R87.624Cytologic evidence of malignancy on smear of vagina R87.625Unsatisfactory cytologic smear of vagina R87.628Other abnormal cytological findings on specimens from vagina R87.629Unspecified abnormal cytological findings in specimens from vagina

Abrechnung und Kostenübernahme

Wann ICD-10-CM vorgeschrieben ist

Für US-Diagnoseabrechnungen nach HIPAA ist ICD-10-CM seit dem 1. Oktober 2015 vorgeschrieben.

Für ambulante und ärztliche Abrechnungen gilt das Leistungsdatum, für stationäre Krankenhausfälle das Entlassungsdatum. Frühere Behandlungen verwenden ICD-9-CM; auch der einzelne Code muss am maßgeblichen Datum gültig sein.

Offizielle Kodierrichtlinien → · CMS ↗

Erstmals erfasst · 2015-10-01

Codeverlauf

Keine Änderung seit der ersten Erfassung

GeändertUnverändert

FY2016

Gültig ab 2015-10-01

Erstmals erfasst

Abnormal cytological findings in specimens from vagina

Kategorie — spezifischeren Code auswählen

CDC/NCHS · FY2016

Alle Ausgaben (19)

Alle Ausgaben	Gültig ab	Codeverlauf
FY2016	2015-10-01	Erstmals erfasst
FY2017	2016-10-01	Keine tabellarische Änderung
FY2018	2017-10-01	Keine tabellarische Änderung
FY2019	2018-10-01	Keine tabellarische Änderung
FY2020	2019-10-01	Keine tabellarische Änderung
FY2020 · April	2020-04-01	Keine tabellarische Änderung
FY2021	2020-10-01	Keine tabellarische Änderung
FY2021 · 01-01	2021-01-01	Keine tabellarische Änderung
FY2022	2021-10-01	Keine tabellarische Änderung
FY2022 · 04-01	2022-04-01	Keine tabellarische Änderung
FY2023	2022-10-01	Keine tabellarische Änderung
FY2023 · 04-01	2023-04-01	Keine tabellarische Änderung
FY2024	2023-10-01	Keine tabellarische Änderung
FY2024 · 04-01	2024-04-01	Keine tabellarische Änderung
FY2025	2024-10-01	Keine tabellarische Änderung
FY2025 · 04-01	2025-04-01	Keine tabellarische Änderung
FY2026	2025-10-01	Keine tabellarische Änderung
FY2026 · April	2026-04-01	Keine tabellarische Änderung
FY2027	2026-10-01	Keine tabellarische Änderung

Hinweise zum Code

Excludes 1

abnormal cytological findings in specimens from cervix uteri (R87.61-)
abnormal cytological findings in specimens from other female genital organs (R87.69)
carcinoma in situ of vagina (histologically confirmed) (D07.2)
vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
severe dysplasia of vagina (histologically confirmed) (D07.2)

Excludes 2

vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)

Use additional code

code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)

Hinweise übergeordneter Ebenen

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

Note

This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
The conditions and signs or symptoms included in categories R00-R94 consist of:
(a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
(b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
(c) provisional diagnosis in a patient who failed to return for further investigation or care;
(d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
(e) cases in which a more precise diagnosis was not available for any other reason;
(f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

R87 · Abnormal findings in specimens from female genital organs

Includes

abnormal findings in secretion and smears from cervix uteri
abnormal findings in secretion and smears from vagina
abnormal findings in secretion and smears from vulva

Spezifischere Codes

Abnormal cytological findings in specimens from vagina

Hinweise zum Code

Use additional code

code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)

Excludes 1

abnormal cytological findings in specimens from cervix uteri (R87.61-)
abnormal cytological findings in specimens from other female genital organs (R87.69)
carcinoma in situ of vagina (histologically confirmed) (D07.2)
vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
severe dysplasia of vagina (histologically confirmed) (D07.2)

R83-R89 · Hinweise übergeordneter Ebenen

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2 · 9

R87.62

Excludes 2

vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

Spezifischere Codes

Abrechnung und Kostenübernahme

Wann ICD-10-CM vorgeschrieben ist

Für US-Diagnoseabrechnungen nach HIPAA ist ICD-10-CM seit dem 1. Oktober 2015 vorgeschrieben.

Offizielle Kodierrichtlinien → · CMS ↗

Erstmals erfasst · 2015-10-01

Codeverlauf

Keine Änderung seit der ersten Erfassung

GeändertUnverändert

FY2016

Gültig ab 2015-10-01

Erstmals erfasst

Abnormal cytological findings in specimens from vagina

Kategorie — spezifischeren Code auswählen

CDC/NCHS · FY2016

Alle Ausgaben (19)

Alle Ausgaben	Gültig ab	Codeverlauf
FY2016	2015-10-01	Erstmals erfasst
FY2017	2016-10-01	Keine tabellarische Änderung
FY2018	2017-10-01	Keine tabellarische Änderung
FY2019	2018-10-01	Keine tabellarische Änderung
FY2020	2019-10-01	Keine tabellarische Änderung
FY2020 · April	2020-04-01	Keine tabellarische Änderung
FY2021	2020-10-01	Keine tabellarische Änderung
FY2021 · 01-01	2021-01-01	Keine tabellarische Änderung
FY2022	2021-10-01	Keine tabellarische Änderung
FY2022 · 04-01	2022-04-01	Keine tabellarische Änderung
FY2023	2022-10-01	Keine tabellarische Änderung
FY2023 · 04-01	2023-04-01	Keine tabellarische Änderung
FY2024	2023-10-01	Keine tabellarische Änderung
FY2024 · 04-01	2024-04-01	Keine tabellarische Änderung
FY2025	2024-10-01	Keine tabellarische Änderung
FY2025 · 04-01	2025-04-01	Keine tabellarische Änderung
FY2026	2025-10-01	Keine tabellarische Änderung
FY2026 · April	2026-04-01	Keine tabellarische Änderung
FY2027	2026-10-01	Keine tabellarische Änderung

Hinweise zum Code

Excludes 1

abnormal cytological findings in specimens from cervix uteri (R87.61-)
abnormal cytological findings in specimens from other female genital organs (R87.69)
carcinoma in situ of vagina (histologically confirmed) (D07.2)
vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
severe dysplasia of vagina (histologically confirmed) (D07.2)

Excludes 2

vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)

Use additional code

code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)

Hinweise übergeordneter Ebenen

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

Note

This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
The conditions and signs or symptoms included in categories R00-R94 consist of:
(a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
(b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
(c) provisional diagnosis in a patient who failed to return for further investigation or care;
(d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
(e) cases in which a more precise diagnosis was not available for any other reason;
(f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

R87 · Abnormal findings in specimens from female genital organs

Includes

abnormal findings in secretion and smears from cervix uteri
abnormal findings in secretion and smears from vagina
abnormal findings in secretion and smears from vulva

Abnormal cytological findings in specimens from vagina

Hinweise zum Code

R83-R89 · Hinweise übergeordneter Ebenen

R87.62

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Spezifischere Codes

Abrechnung und Kostenübernahme

Codeverlauf

Alle Ausgaben (19)

Hinweise zum Code

Hinweise übergeordneter Ebenen

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

R87 · Abnormal findings in specimens from female genital organs

Spezifischere Codes

Verwandte Codes

Abnormal cytological findings in specimens from vagina

Hinweise zum Code

R83-R89 · Hinweise übergeordneter Ebenen

R87.62

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Spezifischere Codes

Abrechnung und Kostenübernahme

Codeverlauf

Alle Ausgaben (19)

Hinweise zum Code

Hinweise übergeordneter Ebenen

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

R87 · Abnormal findings in specimens from female genital organs

Spezifischere Codes

Verwandte Codes

Code	Beschreibung	Kategorie · weitere Spezifizierung erforderlich
R87.61	Abnormal cytological findings in specimens from cervix uteri	Kategorie · weitere Spezifizierung erforderlich
R87.69	Abnormal cytological findings in specimens from other female genital organs	Abrechenbarer, spezifischer Code